







Age (years) 54.0  10.6 59.8  9.4 64.1  8.9 <0.01
Male gender (%) 7 (26.9) 28 (59.6) 21 (65.6) <0.01
BMI (kg/m2) 29.7  4.0 29.9  4.7 28.8  6.0 0.62
Waist circumference (cm) 99.2  8.9 105.9  10.3 102.6  9.1 0.17
Current smoker (%) 6 (23.1) 10 (21.3) 10 (31.2) 0.79
Hypertension (%) 11 (42.3) 18 (38.3) 13 (40.6) 0.91
Diabetes mellitus (%) 5 (19.2) 11 (23.4) 8 (25.0) 0.85
Dyslipidemia (%) 4 (15.4) 8 (17.0) 6 (18.7) 0.44
Vessel score 0 0 0.8  1.1
(0–4)
<0.001





Galectin-3 (ng/mL) 5.69  2.34 13.53  2.10 19.16  1.37 <0.001
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Objectıve: Heart rate recovery (HRR) is inﬂuenced by autonomic function. Percu-
taneous coronary intervention (PCI) improves cardiac symptoms and reduces
morbidity and mortality in coronary artery disease (CAD). We aimed to investigate the
effect of PCI on HRR and the relationship of HRR index with the degree of coronary
stenosis in patients with severe stable CAD.
Methods: The treatment group (TG) consisted of 70 severe stable CAD patients
treated with PCI, and the control group (CG) with 62 minimal CAD patients, who
were not treated with PCI. All participants underwent exercise test both at baseline and
3 months after coronary angiography (CAG)/PCI. HRR was deﬁned as a change in
HR from peak exercise to 1 minute after exercise. HRR index was described as the
percentage change in HRR from 3 months after CAG/PCI to baseline.
Results: HRR was lower in the TG at baseline (p<0.05), and showed a signiﬁcant
increase after 3 months, when compared with baseline data (p<0.001). In the TG, while
HRR was inversely correlated with the number of diseased coronary artery at baseline
(r¼-0.418, p<0.001), this correlation was not observed after 3 months (p¼0.602). HRR
index was higher in the TG than the CG (p<0.001). No associations were found
between HRR (p¼0.136), HRR index (p¼0.703) and the severity of coronary stenosis.
Patients who had multiple vessels treated, had the highest HRR index.
Conclusıon: Our results showed that PCI is associated with improved HRR in
proportion to the number of coronary vessels treated in severe stable CAD. In addition
to standard exercise test data, the use of HRR may be beneﬁcial for the risk stratiﬁ-
cation and follow-up of those patients.
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Purpose: Galectin-3 (Gal-3) is a beta-galactoside-binding lectin expressed by acti-
vated macrophages and involved in crucial steps of atherogenesis. Circulating levels
of Gal-3 has emerged as a novel informative biomarker in patients with acute ST-
segment elevation myocardial infarction and congestive heart failure. The aim of this
study is to investigate clinical relevance of circulating Gal-3 levels in patents who
underwent coronary angiography with suspected CAD.
Methods: One hundred and ﬁve consecutive patients (49 females, 56 males; mean age
59.7 years) who underwent ﬁrst-time diagnostic coronary angiography from March
2013 to June 2013 were included in this study. Peripheral blood samples were taken
from antecubital vein for determination of serum Gal-3 concentrations before coronary
angiography. Serum Gal-3 levels were determined by a commercially available
sandwich enzyme-linked immunosorbent assay kit (catalog no: BMS279/2, Bender
medSystems GmbH, Vienna, Austria). The measuring range of the assay 0.39-25 ng/
mL. Intra-assay and inter-assay coefﬁcients of variant were <5%. Patients were
divided into three groups according to degree of coronary stenosis: normal coronary
arteries (26 patients, group 1), non-signiﬁcant (<50%) stenosis (47 patients, group 2),
and critical (>50%) stenosis (32 patients, group 3). The severity and extent of CAD
was evaluated by calculation of vessel and Gensini scores.
Results: Demographic and clinical characteristics of the patients were listed in Table
1. Patients with CAD (groups 2 and 3) were mostly males and they were signiﬁcantly
older in respect to group 1 (p<0.01). Serum Gal-3 levels were highest in group 3
(19.16  1.37 ng/mL), and also signiﬁcantly elevated in group 2 compared to group 1
(13.53  2.10 vs 5.69  2.34 ng/mL; p<0.001). Serum Gal-3 levels were correlated
with the number of diseased vessels and Gensini score (Figure 1).
Conclusıons: We demonstrated that serum levels of Gal-3 is a useful biomarker of
coronary atherosclerotic involvement in patients who underwent ﬁrst time diagnostic
coronary angiography with suspicion of CAD.JACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTPP-255
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Objectıve: Sufﬁcient coronary collateral circulation (CCC) protects myocardial tissue
against ischemia in patients with coronary chronic total occlusion (CTO). In this
study, we aimed to investigate whether there is an association between serum g-
glutamyl transferase (GGT) levels and development of CCC in patients with coronary
CTO.
Methods: A total of 203 patients with CTO at coronary angiography were included in
this study. On the day of admission to the hospital, blood samples were taken and
GGT levels were analyzed for all patients. Development of collateral circulation was
graded according to the Rentrop classiﬁcation after coronary angiography. Then,
patients were divided into two groups on the basis of CCC grades: group 1 included
99 patients (49%) with poorly developed CCC, and group 2 included 104 patients
(51%) with well-developed CCC.
Results: Patients with poorly developed CCC had signiﬁcantly higher serum GGT
levels compared with those with well-developed CCC, (66.516 vs. 51.810 U/l,
p<0.0001). Correlation analysis showed an inverse correlation between GGT levels
and the Rentrope score (r¼-0.579, p<0.001). Logistic regression analysis showed that
GGT level was an independent predictor of poorly developed CCC (odds ratio 0.92,
95% conﬁdence interval 0.90-0.94; p<0.001).
Conclusıon: Increased serum GGT levels independently predict poorly developed
CCC in patients with coronary CTO. Our results show that GGT is a simple and
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Introductıon: Resistin which is derived by the gene of RSTN, belongs to a family
cysteine-rich secretory proteins called resistin-like molecules (RELM). It was ﬁrst
characterized in murine models as a hormone associated with obesity and insulin
resistance. The increased serum resistin levels are associated with coronary artery
disease (CAD) and the risk of cardiovascular (CV) death.
Materıal-Method: The study group consisted of 214 patients who underwent coro-
nary angiogram due to stable angina pectoris (SAP) or unstable angina pectoris
(USAP) and acute coronary syndrome without ST segment elevation myocardial
infarction (NSTEMI) in Istanbul University Institute of Cardiology between
December 2011 and December 2012. Blood samples were collected from each patient
before coronary angiography; 5 ml of blood were drawn in tubes without anticoag-
ulant. Serum resistin concentrations were measured by using a Human Resistin ELISA
assay (Biovendor Company, German). Coronary angiography was performed in all
patients. CAD was deﬁned by a plaque in at least 1 major coronary artery. The Gensini
score was used to determine the severity and extension of CAD.
Results: The serum resistin level in the CAD group (25.5015.44 pg/ml) was
signiﬁcantly higher than the control group (17.128.26 pg/ml) (p:0.003). The serum
resistin level was 25.3913.36 pg/ml in the SAP (p<0.05), 24.9518.01 pg/ml in the
USAP (p<0.05), 28.1616.48 pg/ml in the NSTEMI (p<0.05) groups (Table 1).
Whereas there was no signiﬁcant difference in the serum resistin levels between
NSTEMI, USAP and SAP groups (Table 2). There was a positive correlation between
Gensini score and serum resistin levels (r¼0.360, p¼0.010) according to Spearman's
correlation analysis (Table 3 and Figure 1).C186 JACC VoDıscussıon: In our study we found that serum resistin levels were signiﬁcantly
increased in NSTEMI, USAP and SAP when compared with the controls (p:0.003).
Reilly et al. reported that serum resistin level was independently associated with
coronary artery calciﬁcation (CAC). In contrast to our study, Qiao et al. reported
serum resistin levels increased with the progress of CAD. In their study serum resistin
levels were elevated in the USAP group compared with the SAP group, while the level
was highest in AMI (acute myocardial infarction) patients (p<0.05). In our study there
was a positive correlation between the Gensini score and serum resistin level. This
makes our study different from others because we did not ﬁnd any study examining
the correlation between serum resistin level and Gensini score. In conclusion, we
found that there was a relationship between increased serum resistin level and CAD.
Also, the serum resistin level was positively correlated with the Gensini score. These
observations suggest that resistin may participate in the process of atherosclerosis as
an effector molecule of inﬂammatory reaction. Further investigation is needed to
deﬁne the role of resistin in patients with CAD.l 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTERS
